Bevacizumab (Avastin)

Avastin (Bevacizumab) is a monoclonal antibody medication designed to inhibit vascular endothelial growth factor (VEGF), reducing angiogenesis (the formation of new blood vessels). This action is crucial in controlling the growth of tumors and managing certain types of cancer.

Key Features:

• Active Ingredient: Bevacizumab
• Concentration: 400 mg/16 ml
• Form: Concentrate for solution for infusion
• Manufacturer: Roche

Indications:
Avastin is commonly prescribed for the treatment of:

• Metastatic colorectal cancer (mCRC)
• Non-small cell lung cancer (NSCLC)
• Glioblastoma
• Renal cell carcinoma (RCC)
• Cervical cancer

Administration and Dosage:

• Administered via intravenous infusion under medical supervision.
• Dosage varies based on the type of cancer and individual patient needs.
• Consult a healthcare professional for specific dosage and administration instructions.

Storage Instructions:

• Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Do not freeze.
• Protect from light.

Precautions:

• Monitor for signs of gastrointestinal perforations, bleeding, and thromboembolic events.
• Avoid use during pregnancy.
• Consult your physician for a detailed list of precautions and possible side effects.

Note: This is a prescription-only medication and should be used under the guidance of a healthcare professional.